⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoramidic Acid SCHEMBL220946 | 0.98 | LAP3 (0.32) | — | |
| SCHEMBL2524893 | 0.79 | CA2 (0.33) | — | |
| SCHEMBL1514201 | 0.79 | — | — | |
| SCHEMBL3693476 | 0.79 | CTSA (0.32) | — | |
| SCHEMBL8399409 | 0.76 | — | — | |
| Phosphoric Acid SCHEMBL26662213 | 0.75 | CA2 (0.38) | — | |
| Ammonia Solution, Strong SCHEMBL27820268 | 0.74 | — | — | |
| SCHEMBL2048661 | 0.73 | CTSA (0.35) | — | |
| SCHEMBL8724557 | 0.71 | — | — | |
| SCHEMBL4951275 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12458705-B2 | Antibody-oligonucleotide conjugates | ANGIEX, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| EP-4475891-A2 | ENHANCED DNA DENDRIMERS AND METHODS OF USE THEREOF | Code Biotherapeutics, Inc. (US) | 2024-12-18 | — | — | EP | disclosed |
| US-20230338557-A1 | ENHANCED DNA DENDRIMERS AND METHODS OF USE THEREOF | CODE BIOTHERAPEUTICS, INC. | 2023-10-26 | — | — | US | disclosed |
| WO-2023154788-A2 | ENHANCED DNA DENDRIMERS AND METHODS OF USE THEREOF | CODE BIOTHERAPEUTICS, INC. (US) | 2023-08-17 | — | — | WO | disclosed |
| US-20230015276-A1 | METHODS AND COMPOSITIONS TO INCREASE SOMATIC CELL NUCLEAR TRANSFER (SCNT) EFFICIENCY BY REMOVING HISTONE H3-LYSINE TRIMETHYLATION | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2023-01-19 | — | — | US | disclosed |
| US-20220265770-A1 | TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN | NEURODYN INC (CA) | 2022-08-25 | — | — | US | disclosed |
| US-20220242964-A1 | COMPOSITIONS AND METHODS FOR REGULATING ERYTHROPOIESIS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2022-08-04 | — | — | US | disclosed |
| US-11390885-B2 | Methods and compositions to increase somatic cell nuclear transfer (SCNT) efficiency by removing histone H3-lysine trimethylation | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2022-07-19 | — | — | US | disclosed |
| CN-112912110-A | Antibody-oligonucleotide conjugates | 安吉克公司 | 2021-06-04 | — | — | CN | disclosed |
| CN-112135907-A | Peptide nucleic acid complexes with inclusion body escape capability and uses thereof | 海阳制药股份有限公司 | 2020-12-25 | — | — | CN | disclosed |
| US-5734040-A | OLIGONUCLEOTIDES WITH ETHYLENEDIAMINE PHOSPHORAMIDATE FOR DNA | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1998-03-31 | — | — | US | disclosed |
| WO-1998003533-A1 | ANTISENSE OLIGONUCLEOTIDES AS ANTIBACTERIAL AGENTS | OLIGOS ETC. AND OLIGOS THERAPEUTICS, INC. (US) | 1998-01-29 | — | — | WO | disclosed |
| EP-0498843-B1 | OLIGONUCLEOTIDE ANALOGS WITH NOVEL LINKAGES | GILEAD SCIENCES INC (US) | 1996-06-12 | — | — | EP | disclosed |
| US-5495009-A | TREATING WITH BROMINE IN PRESENCE OF 2,6-DIETHYLPYRIDINE AND MOLECULAR SIEVES FOLLOWED BY TREATMENT WITH TETRABUTYLAMMONIUM FLUORIDE IN TETRAHYDROFURAN | GILEAD SCIENCES, INC. (US) | 1996-02-27 | — | — | US | disclosed |
| US-5264564-A | DNA or RNA and gene expression | GILEAD SCIENCES (US) | 1993-11-23 | — | — | US | disclosed |
| US-5264562-A | Replacement of phosphodiester linkages with some acetal/ketal type, resistant to nuclease digestion | GILEAD SCIENCES, INC. (US) | 1993-11-23 | — | — | US | disclosed |
| WO-1992019637-A1 | OLIGONUCLEOTIDE ANALOGS CONTAINING THIOFORMACETAL LINKAGES | GILEAD SCIENCES, INC. (US) | 1992-11-12 | — | — | WO | disclosed |
| EP-0498843-A4 | OLIGONUCLEOTIDE ANALOGS WITH NOVEL LINKAGES | — | 1992-11-04 | — | — | EP | disclosed |
| EP-0498843-A1 | OLIGONUCLEOTIDE ANALOGS WITH NOVEL LINKAGES. | GILEAD SCIENCES INC (US) | 1992-08-19 | — | — | EP | disclosed |
| WO-1991006629-A1 | OLIGONUCLEOTIDE ANALOGS WITH NOVEL LINKAGES | GILEAD SCIENCES, INC. (US) | 1991-05-16 | — | — | WO | disclosed |